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Introduction
There is increasing demand upon gastrointestinal diagnostic services, including diagnostic UGI endoscopy. The majority of new referrals for UGI endoscopy originate from primary care physicians' who refer via a direct-to-test pathway. In the UK direct-to-test UGI endoscopy can be accessed through two distinct pathways: referrals are made either through a routine "open access" (OA) referral system, or through a fast tracked, cancer exclusion service in which patients receive their gastroscopy within 2 weeks of referral (2WR) [1] . As a result the majority of studies assessing dual focus endoscopy are conducted using such a referral population.
These referral pathways aim to reduce unnecessary outpatient consultations and streamline the diagnostic algorithm for patients [2] , and have been adopted globally [3, 4] . However the effectiveness of direct-to-test referral has been refuted by some authors because of a perceived increase in inappropriate referrals when comparing direct-to-test endoscopy to endoscopy with a prior GI consultation [5] .
Both the American Society for Gastrointestinal Endoscopy (ASGE) and National Institute for Health and Care Excellence (NICE) have produced guidance documents which support the use of direct-to-test referral routes for diagnostic UGI endoscopy [6] , and adherence to these guidelines has been shown to improve the yield of clinically relevant findings at UGI endoscopy [6] [7] [8] .
These guidelines focus on appropriateness of referral, patient acceptance and preparedness for endoscopy, informed consent, and assurance of appropriate follow-up, however in addition to these service level factors recent technical advances in endoscope design may also influence the diagnostic yield of UGI endoscopy. High-definition, high-magnification endoscopy, with or without mucosal enhancement techniques by indigo carmine 4 chromoendoscopy or blue light endoscopy, enable more detailed visualization of GI mucosa than was achievable using earlier generation endoscopic equipment, and may allow improved detection and classification of GI mucosal lesions leading to better biopsy targeting [9] .
Since January 2015, patients attending our teaching hospital for direct-to-test UGI endoscopy have been allocated either an Olympus GIF-HQ290 dual-focus magnification, high-definition gastroscope or an older generation video gastroscope (Olympus GIF-H260 or GIF-Q240). We aimed to establish whether the use of dual-focus magnification, high-definition endoscopy influenced the diagnostic yield in patients attending our service for open access diagnostic UGI endoscopy.
Method
A retrospective observational study of factors that influence identification of significant pathology during direct-to-test UGI endoscopy was performed in a university teaching hospital. Endoscopists consisted of nurses, specialist gastroenterology trainees and consultants. All of which were Joint Advisory Group (JAG) accredited endoscopists. All patients referred, between January 2015 and June 2015, through a direct-to-test pathway and who underwent a completed UGI endoscopy were included. Data were collected using the Unisoft endoscopy reporting software and hospital pathology database. The primary outcome of interest was the identification of significant pathology, defined as mucosal ulceration, stricture formation, biopsy proven cancer, biopsy proven Barrett's oesophagus or Helicobacter pylori positive gastritis, The latter two diagnoses were included due to their premalignant potential.
Any other findings were defined as non-significant and are summarised in supplementary table 1. were used for statistical analyses. A p value of <0.05 was considered as statistically significant.
Results

Patient demographics
6 500 endoscopies were included in the study. In keeping with our known departmental practice 77% of procedures were performed by nurse endoscopists, the remainder being performed by a mixture of training grade (16%) and non-training grade (7%) doctors.
Ninety four gastroscopies were carried out using the dual-focus magnification, highdefinition gastroscope, the remaining 406 were conducted with, for the purposes of this study, 
Multivariate analysis
As univariate analysis identified a number of potentially confounding factors that influenced the frequency of identifying significant pathology in direct-to-test UGI endoscopy we built a logistic regression model to determine what impact specific variables had on diagnostic yield (Table 2 ).
In this model advancing age was identified as a statistically significant risk factor for the identification of pathology, though the effect size was extremely small (OR 1.01 (95% CI 1.00-1.02). In keeping with previous literature, male gender was also identified as a risk 8 factor for the identification of significant pathology and conferred an odds ratio of 1.59 (95% CI 1.04-2.43). As in the univariate analysis, mode of referral did not influence the risk of identifying significant pathology. The type of operator did contribute to diagnostic yield in the multivariate analysis, with training grade doctors 3.7 (1.34-12.05) times more likely to identify pathology than their non-training grade colleagues. The use of dual-focus magnification, high-definition endoscopes was also identified as an independent factor in the identification of significant UGI pathology and conferred an odds ratio of 1.87 (95% CI 1.11-3.12) for identifying significant pathology over the use of other endoscope series.
Dual-focus magnification, high-definition endoscopy influences outcome following endoscopy
Having identified that the identification of significant pathology is influenced by the use of dual-focus magnification, high-definition endoscopy we wanted to characterise whether this endoscopy system also influenced the ongoing care provided to patients. We therefore categorised patient outcomes following endoscopy into hospital outpatient or MDT followup, an acute repeat UGI endoscopy, repeat endoscopy for surveillance, or discharge to the primary care physician. Acute repeat gastroscopies were defined as a further procedure within three months, and were requested either for interventional therapies including oesophageal dilatation, or to asses healing of mucosal lesions identified in the initial endoscopy.
There was a significant (p=0.04, χ 2 test) difference in the outcome of endoscopies following dual-focus magnification, high-definition endoscopy with a 3.0-fold increase in the proportion of patients entering an endoscopic surveillance program than in the group who were examined with conventional endoscopes ( figure 3 ).
Non-trainee doctors discharged a higher percentage of patients, followed by nurse and trainee doctors (91.42, 83.72 and 78.2% respectively). Nurses and non-trainee doctors enrolled 9 patients into surveillance at a very similar rate, 2.84 and 2.85% respectively. With trainee doctors having the greatest rate of surveillance enrolment at 5.12%.
Dual-focus magnification, high-definition endoscopy aids diagnosis of significant oesophageal and gastric pathology
To determine whether dual-focus magnification, high-definition endoscopy might have an impact on the identification of lesions in a specific part of the UGI tract we categorised pathology by location and performed contingency table analyses. This demonstrated significant differences in distribution (p=0.01 by c 2 test) with a 1.3 fold higher proportion of procedures identifying significant oesophageal pathology when procedures were performed with endoscopy compared to other endoscope series and a 2.7 fold increase in identification of gastric pathology (Table 3 and Figure 4 ). Significant duodenal pathology was identified in less than 1% of procedures and was not identified during any of the 94 endoscopies performed using a high-definition, high-magnification endoscope, hence this site was excluded from this analysis.
Comparing the standard and high definition scopes, all endoscopic findings were also subjected to univariate analysis (Table 4 ). This demonstrated a superior ability for the high definition scope to identify Barrett's oesophagus , gastric ulcers and gastritis. There was no difference in the identification of established oesophageal cancer. Insufficient duodenal pathology was identified to characterise statistically significant differences.
Discussion
This study demonstrates dual-focus magnification, high-definition endoscopy as an independent factor in the identification of significant mucosal pathology in patients attending for direct-to-test UGI endoscopy. In a multivariate analysis these endoscopes conferred a 1.87 10 fold increased odds of identifying pathology over the previously adopted standard endoscopes in our department. This increased ability to detect pathology also appears to have influenced the outcomes for patients included in the study. People who were examined with a dual-focus magnification, high-definition endoscope were approximately 3 times as likely to be entered into a Barrett's oesophagus surveillance programme as those in whom their endoscopy was performed with a standard endoscope. This is in keeping with previous data which have demonstrated utility for this type of endoscope in surveillance of Barrett's oesophagus [10] .
In addition, an increased rate of mucosal pathology was identified in patient's stomachs when dual-focus magnification, high-definition endoscopes were used. The gastric mucosa is recognised to be a particularly challenging area to examine well, with reports of up to 7% of gastric cancers being missed when endoscopy was performed within a year of diagnosis [11] .
Because of this, there has been a drive amongst policy makers to try to improve UGI endoscopy service provision [12] , the data presented here suggest that there may be a role for dual-focus magnification, high-definition endoscopes in this. In our study advanced imaging techniques, such as NBI or AFI, were not utilised. Therefore we are unable to comment on the utility of this system to endoscopically determine malignant potential of neoplastic lesions or significant pathology.
The retrospective design of this study accurately reflects practice in our unit, but does introduce limitations to the study. Of particular note, the distribution of dual-focus magnification, high-definition endoscopes between different users was not random, and we identified a preponderance for their use by non-training grade dosctors.
This observation may reflect the fact that more experienced endoscopists are more comfortable with using new equipment, but we cannot exclude that dual-focus magnification, 11 high-definition endoscopes were used for patients thought to have a higher pre-procedure index of suspicion for pathology.
In this study the majority of procedures were performed by nurse endoscopists, with non- 
